Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Merck & Company (MRK) today and set a price target of $100.00. The company's
Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Merck & Company (MRK – Research Report) today and set
Merck Announces First-Quarter 2020 Financial Results
Demars Financial Group LLC grew its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 2.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm own
Eastern Bank trimmed its holdings in shares of Merck & Co., Inc. (NYSE:MRK) by 3.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The ins
Cornerstone Investment Partners LLC lessened its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 1.5% during the first quarter, according to the company in its most recent 13F filing with the SEC.
Cubic Asset Management LLC lessened its holdings in Merck & Co., Inc. (NYSE:MRK) by 2.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Argyle Capital Management Inc. lessened its stake in Merck & Co., Inc. (NYSE:MRK) by 0.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8
Phibro Animal Health (NASDAQ:PAHC) and Poniard Pharmaceuticals (OTCMKTS:PARD) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of t
Bayer (FRA:BAYN) has been given a €76.00 ($88.37) price objective by analysts at Goldman Sachs Group in a research report issued to clients and investors on Tuesday, Borsen Zeitung reports. The firm
Nichols & Pratt Advisers LLP MA grew its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 0.2% during the first quarter, according to the company in its most recent disclosure with the Securities an
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...
OLD National Bancorp IN grew its holdings in Merck & Co., Inc. (NYSE:MRK) by 11.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor o
Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE